Now Playing
97X
Last Song Played
Your New Alternative
On Air
No Program
Now Playing
97X
Last Song Played
Your New Alternative

Posted: May 21, 2018

Aimovig: New migraine prevention drug approved by FDA

Migraines Could Be Triggered By Gut Bacteria

Related

Aimovig: New migraine prevention drug approved by FDA
An artist's rendering of the packaging for the drug Aimovig, the first in a new class of long-acting drugs designed to prevent chronic migraines. (Amgen Inc. via AP)

By Michelle Ewing, Cox Media Group National Content Desk

TRENTON, N.J. —

If you suffer from chronic migraines, relief is here.

According to The Associated Press, the Food and Drug Administration last week approved Aimovig, a monthly shot that aims to reduce migraines. The drug, developed by Amgen Inc. and Novartis AG, is "injected monthly just under the skin using a pen-like device," the AP reported. Its price tag: $6,900 annually before insurance.

>> On ActionNewsJax.com: New drug could reduce migraines

But how does Aimovig work? The FDA said it blocks "the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks." Amgen researchers said participants in one study saw their migraines reduced by half and experienced "minor side effects" like colds, the AP reported.

>> Read more trending news 

If Aimovig doesn't sound right for you, you're still in luck: Three similar shots and various pills to combat migraines are in the works.

Read more here.

– The Associated Press contributed to this report.


There are no comments yet. Be the first to post your thoughts. or Register.

 
 

97X Poll of The Week

 

 

Instagram

 

TWITTER